International Flavors & Fragrances Inc. (IFF)

In the past six months, IFF's stock has been impacted by several key events. In Q3 2025, IFF reported results that beat revenue and adjusted EPS expectations, but overall sales fell year-on-year, and the full-year revenue guidance was slightly below analyst estimates. In Q4 2025, the company's revenue exceeded analyst estimates, despite a year-on-year decline, but adjusted EPS missed expectations. IFF reported a full-year 2025 net loss, primarily due to a goodwill write-down on its Food Ingredients segment, but made progress in strengthening its balance sheet. IFF completed the divestiture of its Soy Crush, Concentrates, and Lecithin Businesses in early March 2026, following the initiation of a formal sale process for its Food Ingredients segment. IFF also divested its Pharma Solutions business in May 2025. IFF declared a dividend for the first quarter of 2026 in March 2026. International Flavors & Fragrances insiders have bought more company stock than they have sold, and the company has received a consensus rating of "Moderate Buy" from analysts.

General demand for International Flavors & Fragrances' products has been weak over the last three years, with overall sales declining annually, but there are variations across segments. The pharma and health solutions segment has shown steady demand, helping to offset challenges in the food ingredients division. The Health & Biosciences segment has been a strong performer, driven by demand for cultures, enzymes, and probiotics. The Scent segment, particularly Fine Fragrance, has also demonstrated strong growth. The company's diverse portfolio across various consumer goods industries suggests that demand can be influenced by broader consumer trends and economic conditions.

International Flavors & Fragrances, Inc. (IFF) is a global leader in sensory and ingredient solutions, creating and manufacturing a wide array of products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories. The company operates within the Specialty Chemicals and Materials sectors. IFF develops and markets innovative ingredients for the food, beverage, health, biosciences, and scent industries globally. Its major product categories include taste, food ingredients, health & biosciences, and scent. IFF is headquartered in New York City and is a component of the S&P 500 index.

IFF has a significant global presence, with facilities in approximately 44 to 65 countries worldwide, and over 70% of its revenue is generated outside North America. The company operates across Greater Asia, Europe, the Middle East & Africa, Latin America, and North America. IFF is expanding its Latin American footprint with a new enzyme hub and Brazil application lab, and a new global business center is set to open in Mexico City in 2026.

In the past year, IFF has continued to emphasize its commitment to sustainability and innovation. The company has been recognized with P&G External Business Partner 2025 Awards for its Scent team and Health & Bioscience team. IFF actively promotes sustainability initiatives, including goals for net-zero carbon emissions by 2040 and reductions in water and energy consumption. The company also sponsors events focused on health and wellness, functional ingredients, and food and beverage technology. However, IFF also faces ongoing antitrust investigations and class-action lawsuits, which are considered key risks for the company.

International Flavors & Fragrances (IFF) is predominantly owned by institutional investors, who collectively hold approximately 91.96% to 96.02% of the company's stock. Major institutional shareholders include Dodge & Cox, Vanguard Group Inc., Freemont Capital Pte Ltd, BlackRock, Inc., and State Street Corp. Significant individual shareholders include Winder Investment Pte Ltd and Foundation Haldor.